Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease

Glob Heart. 2015 Jun;10(2):99-110. doi: 10.1016/j.gheart.2015.04.003.

Authors

Pablo Perel¹, Alvaro Avezum², Mark Huffman³, Prem Pais⁴, Anthony Rodgers⁵, Rajesh Vedanthan, David Wood⁶, Salim Yusuf⁷

Affiliations

¹ World Heart Federation, Geneva, Switzerland, and the London School of Hygiene & Tropical Medicine, London, United Kingdom. Electronic address: Pablo.Perel@worldheart.org.
² Dante Pazzanese Institute of Cardiology, São Paulo, Brazil.
³ Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁴ St. John's Research Institute, Bangalore, India.
⁵ The George Institute for Global Health, Sydney, New South Wales, Australia.
⁶ International Centre for Circulatory Health, Imperial College London, London, United Kingdom.
⁷ Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

PMID: 26213297
DOI: 10.1016/j.gheart.2015.04.003

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
American Heart Association
Atherosclerosis / mortality
Atherosclerosis / prevention & control*
Coronary Artery Disease / mortality
Coronary Artery Disease / prevention & control*
Developed Countries
Developing Countries
Global Health
Guidelines as Topic*
Health Planning Organizations / standards
Humans
Morbidity
Tobacco Use Cessation
United States

Substances

Adrenergic beta-Antagonists